- Indiana board rejects IU Health hospital drug diversion settlement deal
- 5 updates on GLP-1 drugs: Pricing, access, FDA scrutiny
- New Hampshire hospital taps Chicago system exec as CEO
- Monument Health using generative AI tools in Epic
- Recently launched Massachusetts system taps 2 executives
- HCA Florida hospital promotes CFO to CEO
- What the largest DSOs accomplished in Q1
- Sutter Health expands wearable ultrasound use
- The procedure gold mine ASCs are sitting on
- Google, J&J Foundation invest $10M in rural healthcare AI training
- AI regrets? Health systems learn lessons from the early boom
- Amazon Health adds strategic growth leader
- ADA updates CDT codes for 2027: 5 notes
- Where the ASC industry is getting the anesthesia conversation wrong
- The payer policies driving the most friction in musculoskeletal care
- Ohio system opens $27.5M outpatient center
- Cleveland Clinic expands pediatric treatments for esophageal disorder
- 4 states disciplining dentists
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Physicians’ broken wRVU model
- Where 2 interstate dental compacts stand in 2026
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- The unsolved problem plaguing ASCs
- 43 states have mental health insurance disparities: 4 trends
- R1 RCM launches AI tools for AR recovery, denials
- The compensation divide between self-employed, employed physicians is shrinking
- The new playbook for clinician well-being
- CFOs as strategists: How finance leaders are rewriting their role
- Listen to the Latest ‘KFF Health News Minute’
- The dual payoff of dental AI
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- CPIhealth acquires Indiana spine ASC
- Small Talk? It May Be Better Than You Think
- 5 anesthesia staffing models ASCs are adopting in 2026
- Ohio long-term acute care hospital to close, lay off 116
- Mount Sinai, Anthem reach 3-year agreement
- Days cash on hand at 50 health systems
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Does Your Child Have Nightmares? Here's One Solution
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Los estados se enfrentan a otro reto con las nuevas reglas laborales de Medicaid: la falta de personal
- States Change Custody Laws To Keep Children of Detained Immigrants Out of Foster Care
- New Orleans Takes Steps To Assess and Clean Lead in Playgrounds After Investigation
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- Maine enacts law expanding scope of practice for independent dental hygienists
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- NYU awarded $5.5M to expand oral health center
- Smile Partners USA partners with Illinois dentist
- Mississippi hospital could close June 15
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- California behavioral health hospital to add inpatient beds
- Freedom of Associations
- When “Fail First” Fails Patients: Why Step Therapy Exception Requests Matter More Than Ever
- Why corporate dentistry gets a bad rap
- ECU dental school expands dental hygienist pipeline with new degree
- Pioneering exposure therapy psychologist dies
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- New Mental Health Parity Index highlights where disparities persist
- How University Hospitals swung to $190M in operating income after years of losses
- CMS taps 150 digital health companies, providers for ACCESS Model
- 10 providers seeking RCM talent
- Optum allows mental health NPs to offer transcranial magnetic stimulation
- National behavioral health association taps president, CEO
- Healthcare spending varies widely between metropolitan areas: HCCI
- CMS’ proposed pay bump inadequate, hospitals say
- Wavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platform
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- AI speeds up prior auth, coding while driving higher costs for health systems: PHTI report
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- How To Make a High-Deductible Health Plan Work for You
- Pennsylvania Town Faces Fallout From Trump’s Environmental Rule Rollback
- CMS showcases first wave of digital health tools as questions about 'last mile' of adoption remain
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- How to Limit The Health Risks Posed by Polluted Air
- U.S. States Warm, But Not As Expected
- Rovner Recaps Medicaid Cuts’ Impact on Hospitals and Fields Caller Questions on Affordability
- UHS’ CEO-to-worker pay ratio over the past 5 years
- 5 new university programs tackling behavioral health workforce gaps
- Texas Children’s gets $5M gift for behavioral health services
- CMS proposes 2.4% hospital pay increase, nationwide mandatory model rollout
- Proposed CMS rule would set prior auth deadlines for drugs
- How Evernorth's new Delaware specialty pharmacy facility highlights a broader care coordination approach
- HHS, after legal setback, updates ACIP charter to put more emphasis on vaccine safety
- HHS, after legal setback, updates ACIP charter to put more emphasis on vaccine safety
- Costco Recalls Cookies Over Missing Nut Allergy Warning
- CDC Pauses Release of COVID Vaccine Effectiveness Study
- Demand Surge Leads to Shortages of Estrogen Patches
- Statement Regarding Staff No-Action Letter to Bank of England
- Op-ed: Administrative fragility is costing healthcare more than we think
- UPDATED: Replimune to reduce workforce following 'disappointing' second rejection for melanoma prospect
- Title X Funding Restored, but New Rules Raise Concerns
- Function Health acquires mobile healthcare platform Getlabs to provide members with at-home lab tests
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- Blackstone and TPG Complete Acquisition of Hologic; Names New CEO
- Blackstone and TPG Complete Acquisition of Hologic; Names New CEO
- Endospan Receives FDA Approval for the NEXUS Aortic Arch Stent Graft System
- Endospan Receives FDA Approval for the NEXUS Aortic Arch Stent Graft System
- InVera Medical Receives FDA Clearance for Non-Thermal Chronic Venous Disease Device
- InVera Medical Receives FDA Clearance for Non-Thermal Chronic Venous Disease Device
- How CVS Caremark is using innovative technology to simplify the prior authorization process
- Starting material sourcing bottlenecks increase US drug shortage risks: report
- Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on
- Charles River flows into Boston to help AHA bridge cardiovascular health divide
- Your Brain Cares If Your Plant-Based Diet Is Unhealthy, Researchers Report
- Your Neighborhood Might Help Make You Old Before Your Time
- Heavy 'Forever Chemical' Exposure Before Birth Increases Childhood Asthma Risk, Study Finds
- High-Tech Magnets Offer New Hope for Veterans Battling Combat PTSD
- Early Diagnosis Key To ADHD Child's Academic Success, Study Finds
- Study Reveals Who Americans Think Should Pay for Elder Care
- Envision hires ConcertAI, IQVIA alum Nick Jones as its med comms president
- The top 10 pharma R&D budgets of 2025
- Bial launches ‘Dialogues with Parkinson’s’ campaign aimed at identifying early symptoms
- Novartis pumps up community health footprint to tackle heart disease and cancer
- Abbott survey finds ‘information overload, confusion and cost’ affecting health choices in US
- FDA accuses Amneal, BioCorRx of producing ‘false and misleading’ drug promos
- Epic rolls out health alerts to flag rising rates of illness at the county level
- Hospital M&A roars back to life in Q1 2026; Operating performances fray in February
- Fierce Pharma Asia—Takeda-Denali split-up; Merck, Zhifei's revised deal; Shionogi's made-in-US plan
- Brain Scans Reveal How Psychedelics Change Perception
- Benefits leaders report increased operational, financial costs amid 'digital health vendor sprawl': Solera survey
- Vanda initiates study of motion sickness drug Nereus in GLP-1 users
- Judge Allows Abortion Pill, Mifepristone, To Continue Being Mailed for Now
- Bangladesh Measles Outbreak Kills 100+ Kids, Emergency Shots Begin
- Regulatory burdens continue to mount for physician practices
- Omnichannel Has an Access Problem. Compliant AI Fixes It.
The recent SCOTUS decision in United States v. Skrmetti, the case upholding Tennessee’s ban on adolescent transgender treatments, has Jonathan Turley examining the decline in America's expert class:
https://jonathanturley.org/2025/06/26/the-icarian-gene-the-rise-and-fall-of-the-expert-class/
The Icarian Gene: The Rise and Fall of the Expert ClassBy Jonathan Turley - June 26, 2025
The warning was stark. At issue was a privileged class that has long dictated policy despite countervailing public opinion. At issue, the luminary warned, is nothing short of democracy itself. No, it was not the continued rallies of Sen. Bernie Sanders (I., VT) to “fight oligarchy.” It was Justice Clarence Thomas rallying his colleagues to fight technocracy, or government by experts. He warned against allowing “elite sentiment” to “distort and stifle democratic debate.” Yet, the story is even more profound of an elite class which succumbed to the Icarian gene and fell to Earth due to hubris and excess.
In his concurrence in United States v. Skrmetti, a case upholding Tennessee’s ban on adolescent transgender treatments, Thomas called for his colleagues to stand against an “expert class” that has dictated both policy and legal conclusions in the United States.
The reference to “experts” is often used to insulate an opinion as self-evidently true on a given question when they speak as a group. It distinguishes the informed from the casual; the certifiably authoritative from the merely interested. Yet, what constitutes an “expert” can be little more than an advanced degree, and the “overwhelming opinion of experts” can be little more than groupthink.
Thomas warned his colleagues that “[t]here are particularly good reasons to question the expert class here, as recent revelations suggest that leading voices in this area have relied on questionable evidence, and have allowed ideology to influence their medical guidance.”
Indeed, those “good reasons” have become increasingly obvious to those outside of the Beltway. The public saw experts line up during the pandemic to support mandatory uses of surgical masks, shutting down schools, and requiring the ruinous six-foot rule of separation. Many of these rules were later found lacking in scientific support. At the same time, dissenting experts, including the signatories of the Great Barrington Declaration, were blacklisted, censored, or fired for challenging these views.
We have seen the same orthodoxy on issues ranging from gender dysphoria to COVID measures.
In his concurrence, Thomas lashed out at the virtual mantra in court papers and the media of an “overwhelming medical consensus” in favor of transitioning children. This is often cited as the conclusive judgment of experts as opposed to citizens who overwhelmingly oppose treatments for children, including castration or surgical removal of genitalia. Thomas insisted that “so-called experts have no license to countermand the ‘wisdom, fairness, or logic of legislative choices.’”
For decades, citizens largely identified the government with bringing modern approaches to programs eliminating long-standing social ills from poverty to illiteracy to inequality. Roughly 100 years ago, the New Deal of Franklin Delano Roosevelt transformed the government’s role in American life. A generation of experts brought new ideas of electrification, education, and economics to the country.
This veneration was furthered by Kennedy’s assemblage of “the best and the brightest” and Johnson’s “Great Society” reformers.
The courts later followed with greater and greater deference afforded to these experts, including the establishment of the “Chevron doctrine” insulating agency decisions from substantial judicial review. The Supreme Court ruled that courts were poorly equipped to second-guess the expertise of agency experts.
The Reagan Revolution challenged those assumptions. Reagan famously told voters that “the nine most terrifying words in the English language are: I’m from the Government, and I’m here to help.”
Over the years, the mystique took on a more menacing aspect for many in the country as they watched academic and scientific groups become more advocates than experts. There seemed to be a shift from making for a better life to making us better people through progressive social agendas.
The result has been a dramatic change in trust for higher education and, by extension, the supremacy of the expert class. According to Gallup, only a third of Americans today have great confidence in higher education and roughly the same number have little or no confidence. That is a drop of over twenty percent in the last ten years.
Other polling shows drops in the trust for state and local public health officials as well as the U.S. Centers for Disease Control and Prevention (CDC).
The decline of the expert class can be traced to the changes in higher education over the last couple of decades. As I discuss in my book The Indispensable Right, an orthodoxy has taken hold of most universities with a purging of conservative, libertarian, and dissenting faculty. Within these ideological echo chambers, appointments, publications, and grants often seem to turn on conclusions that favor political agendas.
Over the years, dissenting faculty members have been forced out of scientific and academic organizations for challenging preferred conclusions on subjects ranging from transgender transitions to COVID-19 protections to climate change. Some were barred from speaking at universities or blacklisted for their opposing views.
As shown during COVID, many of the exiled experts were ultimately proven correct in challenging the efficacy of surgical masks or the need to shut down our schools and businesses. Scientists moved like a herd of lemmings on the origin of the virus, crushing those who suggested that the most likely explanation is a lab leak (a position that federal agencies would later embrace).
Scientists have worked with the government in suppressing dissenting views. At the end of last year, The Wall Street. Journal released a report on how the Biden administration suppressed dissenting views supporting the lab leak theory, as dissenting scientists were blacklisted and targeted.
When experts within the Biden Administration found that the lab theory was the most likely explanation for COVID-19, they were told not to share their data publicly and were warned about being “off the reservation.”
British pediatrician Hilary Cass published a review for NHS England that cast doubt on gender-identity treatments for children and young people. The research reportedly led to an aggressive campaign by the World Professional Association for Transgender Health (WPATH) to suppress the results.
The gravitational pull of social agendas has overwhelmed not just scientific judgment but common sense. For example, there has been a push to treat gender as a socially constructed myth.
A University of Pittsburgh anthropology professor declared that you cannot tell the gender of an individual from their bones – a widely ridiculed assertion.
The editor-in-chief of Scientific American Laura Helmuth made her own contribution to gender ideology by tweeting out a statement with a 2017 article in Audubon Notebook stating “White-throated sparrows have four chromosomally distinct sexes that pair up in fascinating ways. P.S. Nature is amazing[.] P.P.S. Sex is not binary.”
Various experts cried fowl and noted that her point was ideologically driven and scientifically absurd. (Helmuth later resigned after posting a profanity-laden attack on social media calling Trump voters “fascists” and bigots).
In many cases, dissenting views on social or political issues are treated as disqualifying for any research.
At Cornell, professors signed a letter denouncing “informed commentary” critical of violent protests as racist.
In 2020, Harald Uhlig, the senior editor of the prestigious Journal of Political Economy and the Bruce Allen and Barbara Ritzenthaler Professor in Economics at the University of Chicago, criticized Black Lives Matter and the movement to defund the police. The response was a campaign to remove Uhlig from the Journal. Writers like economist Paul Krugman insisted that he was now “yet another privileged white man” attacking the”less fortunate.”
The University of Pittsburgh Medical Center removed Associate Professor of Medicine Norman Wang from his position as Program Director of the Electrophysiology Fellowship after he wrote an article in a peer-reviewed journal questioning the use of affirmative action in medical schools admissions. (Later, the Supreme Court would declare such use of race as unconstitutional race discrimination).
Another controversy arose in 2024 just before the Supreme Court considered access to mifepristone, one of two drugs used for abortions by mail. District Judge Matthew Kacsmaryk relied on two studies that showed harm from the use of the pill.
The Sage journal Health Services Research and Managerial Epidemiology was widely criticized by abortion advocates for publishing the studies. One month before the oral argument, the studies were conveniently retracted and a review published that found the conclusions “invalidated in whole or in part.”
Justices and judges will often take favorable studies as gospel in supporting their legal conclusions. In her dissent in the University of North Carolina affirmative action case, Justice Ketanji Brown Jackson triggered a controversy in citing a 2020 study from a friend-of-the-court brief by the Association of American Medical Colleges. Jackson claimed that race-based admissions “saves lives” because having a Black physician more than doubles the likelihood of the survival of high-risk Black babies. The claim of the brief and the flawed methodology of the study was shredded by critics.
The fact is that it is easy to produce near uniformity of experts since most universities now run from the left to the far left. The combination of biased hiring practices has left most departments with few or no conservative faculty members. As a result, the media can report that liberal positions are supported overwhelmingly by “experts.”
For example, it is now common for the media to report signed letters or petitions of law professors denouncing conservative positions or rulings. It rarely mentions that most law schools have only a couple of conservative faculty members. It is like getting a pro-papal petition from the College of Cardinals. Nevertheless, the coverage leaves the impression that opposing views on transgenderism, gun rights, or other subjects are absurd and rejected by virtually all “experts.”
Both the courts and the public, however, appear to be losing their awe for the expert class. The Supreme Court recently tossed the Chevron Doctrine and called for courts to resume their prior scrutiny of agency decisions.
None of this means that courts or the public should disregard science or experts. Indeed, many experts still follow core principles of unbiased inquiry and discourse. However, good science requires open inquiry and a diversity of viewpoints. Citizens are rejecting science by plebiscite, the self-authenticating petitions where academics purported to speak for an expert class.
The expert class lost the public when they replaced objectivity with orthodoxy. No matter how many experts claim that gender is a social myth, the public is not likely to dispense with reality. The rise and fall of the expert class is a story of the costs of arrogance and excess. Higher education has created a privileged class of social warriors who abandoned core principles of neutrality and objectivity in research. It is an Icarian generation of scholars who flew too close to the sun and fell to Earth in the eyes of the public.
Jonathan Turley is the Shapiro Professor of Public Interest Law at George Washington University where he teaches a course on the Supreme Court. He is the best-selling author of “The Indispensable Right: Free Speech in an Age of Rage” and the forthcoming Rage and the Republic: The Unfinished Story of the American Revolution (Simon & Schuster 2026).
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.


















